CVM (STOCKS)
Cel-Sci Corporation
$4.045000
-0.025000 (-0.61%)
Prev close: $4.070000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Geert R. Kersten
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.21M
- Employees
- 44
- P/E (TTM)
- -0.79
- P/B (TTM)
- 3.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q4)
|
$-2.70 | $-3.33 | +0.6330 | +18.99% |
|
Jun 2024 (Q3)
|
$-4.20 | $-3.94 | -0.2610 | -6.63% |
|
Mar 2024 (Q2)
|
$-4.20 | $-4.24 | +0.0420 | +0.99% |
|
Sep 2023 (Q4)
|
$-4.80 | $-4.85 | +0.0480 | +0.99% |
Financial Statements
| Revenues | -$566.63K |
| Benefits Costs and Expenses | -$50.41M |
| Costs And Expenses | -$38.87M |
| Operating Expenses | $23.29M |
| Depreciation and Amortization | $3.85M |
| Research and Development | $15.13M |
| Other Operating Expenses | $6.23M |
| Operating Income/Loss | -$23.29M |
| Income/Loss From Continuing Operations After Tax | $37.95M |
| Income/Loss From Continuing Operations Before Tax | $43.45M |
| Interest And Dividend Income, Operating | $370.00 |
| Interest Expense, Operating | $567.00K |
| Interest Income/Expense After Provision For Losses | -$566.63K |
| Interest Income/Expense Operating, Net | -$566.63K |
| Net Income/Loss | $37.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $61.76M |
| Net Income/Loss Attributable To Parent | -$23.81M |
| Net Income/Loss Available To Common Stockholders, Basic | -$23.81M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Diluted Earnings Per Share | -$2.05 |
| Diluted Average Shares | 97,715,911 |
| Assets | $22.89M |
| Current Assets | $7.03M |
| Prepaid Expenses | $514.97K |
| Other Current Assets | $6.52M |
| Noncurrent Assets | $15.86M |
| Fixed Assets | $5.57M |
| Other Non-current Assets | $10.29M |
| Liabilities | $11.76M |
| Current Liabilities | $5.04M |
| Accounts Payable | $1.03M |
| Other Current Liabilities | $4.01M |
| Noncurrent Liabilities | $6.72M |
| Equity | $11.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.14M |
| Liabilities And Equity | $22.89M |
| Net Cash Flow From Operating Activities | -$17.00M |
| Net Cash Flow From Operating Activities, Continuing | -$17.00M |
| Net Cash Flow From Investing Activities | $4.67M |
| Net Cash Flow From Investing Activities, Continuing | $4.67M |
| Net Cash Flow From Financing Activities | $18.67M |
| Net Cash Flow From Financing Activities, Continuing | $18.67M |
| Net Cash Flow | $6.34M |
| Net Cash Flow, Continuing | $6.34M |
| Comprehensive Income/Loss | $37.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $37.95M |
| Other Comprehensive Income/Loss | $0.00 |